Pathwest Laboratory Medicine

What Pathwest Laboratory Medicine does

PathWest Laboratory Medicine is a Board-governed Health Service Provider under the Government of Western Australia, operating as one of the largest public pathology services in the Southern Hemisphere. The organization delivers over 14 million pathology tests annually through a statewide network of 30 accredited laboratories and 80 collection centres, serving public hospitals (Fiona Stanley, Sir Charles Gairdner, Perth Children's, King Edward Memorial), the WA Police and justice system, commercial customers, and individual patients. PathWest traces its origins to PathCentre, became an independent Health Service Provider in 2018 under the Health Services Act 2016, and operates from a headquarters at the QEII Medical Centre in Nedlands under a Board chaired by Angie Paskevicius, with Dr Narelle Hadlow appointed Chief Executive in 2024.

The core service portfolio spans eight clinical disciplines: Anatomical Pathology, Biochemistry, Diagnostic Genomics, Forensic Services, Haematology & Blood Transfusion, Immunology, Microbiology, and Point-of-Care Testing. Supporting offerings include Commercial Services (food and water testing, workplace health testing, pharmaceutical testing, media manufacturing), Clinical Trials and Research (including the WACIC COVID-19 Immunity Biobank with over 42,000 biospecimens stored), Perinatal Pathology, and Mortuary Services. Technology investments include digital anatomical pathology, digital morphology in haematology, whole-slide imaging, the Illumina NovaSeq XP sequencer (capable of 600 samples per year with capacity to scale into thousands), and a rapid respiratory point-of-care test detecting up to 15 viral and bacterial pathogens at the bedside. Results flow through the PathWest Healthlink Messaging System; from 1 July 2026, most pathology results will be uploaded to the national My Health Record within 24 hours under Sharing by Default legislation.

PathWest does not operate a typical commercial revenue model. Public healthcare pathology and forensic services are funded through the Western Australian Department of Health under a budget allocation model; commercial testing (food and water, workplace health, pharmaceutical) operates on a fee-for-service, quote-based model; patient-billed pathology relies on Medicare rebates plus no-gap private health insurance arrangements. There is no private equity, no public market listing, no disclosed revenue figure, and no external funding rounds; the organisation is wholly government-owned and has 2,300+ staff (74.4% female) including a COVID-19 Command workforce of up to 250 at pandemic peak.

Name

Pathwest Laboratory Medicine

Legal name

PathWest Laboratory Medicine

Website

https://pathwest.health.wa.gov.au

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

PathWest Laboratory Medicine is a Western Australian government-owned public pathology and forensic service operating 30 accredited laboratories and 80 collection centres, delivering over 14 million diagnostic tests annually to public hospitals, the justice system, and commercial clients.

Ownership category

akta.pro rank

Product category

Public Pathology & Forensic Laboratory Services

NAICS

Medical Laboratories (621511), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industries

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI), Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Public pathology services
• Forensic DNA profiling
• Diagnostic laboratory testing
• Whole genome sequencing
• Blood transfusion services

Headquarters

HQ city

Nedlands

HQ country

Australia

HQ region

Oceania

Offices13 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Others

Revenue model

1. Public Healthcare Pathology Services: Core pathology services funded through the Western Australian public health system, providing diagnostic testing to support healthcare delivery across the state
2. Forensic Services: Forensic DNA profiling and analysis services supporting the Western Australian justice system
3. Commercial Testing Services: Fee-for-service commercial testing including food and water testing, health and workplace testing, pharmaceutical testing, and media manufacturing for external customers
4. Patient Billing: Most pathology tests qualify for Medicare rebate. Private health insurance members billed at no-gap level. Patients without insurance or for non-medical purposes (Workers' Compensation, Motor Vehicle Accident, pre-employment) incur charges

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels7 records

Core offering

PathWest Laboratory Medicine is the public pathology and forensic service provider for Western Australia. It delivers diagnostic pathology across eight clinical disciplines (Anatomical Pathology, Biochemistry, Diagnostic Genomics, Forensic Services, Haematology & Blood Transfusion, Immunology, Microbiology, Point-of-Care Testing), commercial fee-for-service testing (food/water, workplace, pharmaceutical, media manufacturing), perinatal and mortuary services, plus clinical trials and research support. All work is processed through a NATA-accredited network of 30 laboratories and 80 collection centres.

Product overview

PathWest Laboratory Medicine is a public pathology service provider for Western Australia, operating as one of the largest public pathology services in the Southern Hemisphere. The organization delivers over 14 million tests annually through a network of 30 accredited laboratories and 80 collection centres. Its core Clinical Services portfolio includes Anatomical Pathology, Biochemistry, Diagnostic Genomics (featuring the NovaSeq XP whole genome sequencing platform), Forensic Services (with 25 years of NATA accreditation), Haematology & Blood Transfusion, Immunology, Microbiology, and Point-of-Care Testing. Supporting services include Commercial Services (food/water testing, workplace testing, pharmaceutical testing, media manufacturing), Clinical Trials and Research (including the WACIC Biobank), Perinatal Pathology, and Mortuary Services. Results are delivered electronically via the Healthlink Messaging System, and a Respiratory Pathogen Dashboard provides real-time surveillance data to health professionals.

Differentiator

Problem solved

Functional benefit

Products and services

• Anatomical Pathology Histopathology and cytology services examining tissue and cellular samples for disease diagnosis, delivered across the statewide network of laboratories.
• Biochemistry Chemical analysis of blood and body fluids for diagnosis and monitoring of diseases including metabolic disorders, hormone levels and drug monitoring.
• Diagnostic Genomics Genetic testing services including whole genome sequencing, molecular diagnostics and chromosomal analysis for rare diseases and cancer. Houses the NovaSeq XP sequencer for advanced genomic profiling.
• Forensic Services Forensic DNA profiling and forensic biology services supporting the WA justice system, including criminal investigations and missing persons cases. 25 years of continuous NATA accreditation.
• Haematology & Blood Transfusion Blood analysis and transfusion medicine services including blood inventory management, coagulation testing, and blood product issuance across WA.
• Immunology Testing for immune system disorders, allergies, autoimmune diseases and infectious disease serology.
• Microbiology Detection and identification of bacterial, viral, fungal and parasitic infections through culture, PCR and other laboratory methods.
• Rapid Respiratory Point-of-Care Testing Rapid diagnostic testing performed at or near the patient, including the respiratory pathogen panel detecting up to 15 targets within minutes.
• Food and Water Testing Microbiological and chemical testing services for food safety and water quality assurance, sold fee-for-service to commercial clients via quote.
• Health & Workplace Testing Pre-employment screening, occupational health testing and workplace drug testing services for employers and other commercial clients.
• Media Manufacturing Production of culture media and laboratory reagents for internal use and external supply to other laboratories.
• Pharmaceutical Testing Quality control testing services for pharmaceutical products, sold fee-for-service to commercial clients via quote.
• Comprehensive Genomic Profiling (CGP) Program $19M statewide initiative providing comprehensive genomic profiling for all cancer patients in Western Australia, with treatment matching via the Molecular Tumour Board.
• WACIC Biobank Western Australian COVID-19 Immunity Collaborative Biobank storing biospecimens (serum, plasma, whole blood, immune cells, saliva) for COVID-19 research; 682 participants, 1,800+ sample sets and 42,000+ vials stored.
• Perinatal Pathology Specialised pathology services for pregnancy loss, neonatal deaths and fetal abnormalities, providing support and information for families, health professionals and funeral directors.
• Mortuary Services (State Mortuary & PCH Mortuary) Post-mortem examination services including State Mortuary Bereavement Centre and PCH Mortuary services.
• International Traveller COVID-19 PCR Testing COVID-19 PCR testing for international travellers requiring a fit-to-travel certificate; $145 out-of-pocket fee with no Medicare rebate available.
• HPV Self-Collection Self-collection cervical screening option offered as part of HPV testing services, supporting patient choice in screening method.

Quantifiable outcome

• 940 units of blood saved comparing FY2021-22 and FY2022-23, including 778 units from expiry reduction
• +4 more outcomes

Named customers8 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

16 partnerships are on record, tiered core and minor.

• Health Service Providers (WA)coreStrategic or Co-development Partner · 4 February 2024Partnership between PathWest and Health Service Providers for rapid respiratory point of care testing in public emergency departments. Technology detects up to 15 viral and bacterial pathogens within minutes at bedside.
• WA Health SystemcoreStrategic or Co-development Partner · 1 January 2024$19 million Comprehensive Genomic Profiling (CGP) program for all cancer patients. PathWest leads the Community Health and Hospital Program implementing this statewide initiative using massively parallel sequencing technology.
• South Metropolitan Health Service (SMHS)coreStrategic or Co-development Partner · 1 January 2021Collaborative partner in the Western Australian COVID-19 Immunity Collaborative (WACIC) Biobank study. SMHS contributes to the collection of research biospecimens and clinical data for COVID-19 research.
• Child and Adolescent Health Service (CAHS)coreStrategic or Co-development Partner · 1 January 2021Collaborative partner in WACIC Biobank study for COVID-19 immunity research including expansion to children and adolescents.
• Telethon Kids InstitutecoreStrategic or Co-development Partner · 1 January 2021Research partner in WACIC Biobank contributing to understanding of COVID-19 vaccines and immunity in children and adolescents.
• University of Notre Dame AustraliaminorStrategic or Co-development Partner · 1 January 2021Academic partner supporting WACIC Biobank research initiative.
• Murdoch UniversityminorStrategic or Co-development Partner · 1 January 2021Academic partner supporting WACIC Biobank research initiative.
• University of Western Australia (UWA)coreStrategic or Co-development Partner · 1 January 2021Major academic partner supporting WACIC Biobank and broader research programs. Faculty members contribute to PathWest leadership and research.
• Department of Health Western AustraliacoreOthersParent government department providing oversight, funding, and strategic direction for PathWest as a Board-governed Health Service Provider under the Health Services Act 2016.
• International Academy of Pathology (IAP) Australasian DivisionminorOthersProfessional body with which PathWest's Chief Pathologist holds presidency. Supports knowledge exchange and professional development.
• Royal College of Pathologists of Australasia (RCPA)minorOthersProfessional college setting standards for pathology practice. PathWest pathologists hold leadership positions including Structured Pathology Reporting of Cancer Project past chair.
• National Association of Testing Authorities (NATA)coreOthersAccreditation body providing independent recognition of PathWest's technical competence. PathWest maintains continuous NATA accreditation at all collection centres and for Forensic Biology (25 years).
• Australian Digital Health AgencycoreTechnology or IntegrationAgency managing My Health Record national digital system. From 1 July 2026, PathWest will upload most pathology results to My Health Record within 24 hours of finalisation under Sharing by Default legislation.
• WA PolicecoreOthersJustice system partner for forensic DNA profiling services. PathWest forensic scientists have supported major investigations including identification work for criminal cases.
• Genetic Health WAcoreStrategic or Co-development PartnerPartner in rare disease diagnosis and genomic testing programs. Prof Nick Pachter represents Genetic Health WA at events and collaborative initiatives.
• Red Cross LifebloodminorOthersBlood supply partner. PathWest works with Red Cross Lifeblood for blood transfusion services and conservation of voluntarily donated blood resources.

Scale indicators18 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• NSW Health Pathology: NSW Health Pathology is the largest public pathology provider in Australia and operates as a NSW Health state-wide service delivering diagnostic, forensic and research pathology. Like PathWest, it is a state-government-owned entity running a large distributed laboratory network with teaching, research, and forensic mandates.
• SA Pathology: SA Pathology is the public pathology service for South Australia, providing diagnostic, forensic, and specialist laboratory services across multiple metropolitan and regional sites. It is the closest functional analogue to PathWest within Australia: state-mandated service, shared clinical-portfolio breadth, and government governance structure.
• Clinipath Pathology: Clinipath Pathology is a major private pathology provider based in Western Australia, offering diagnostic and specialised testing to GPs, specialists, and corporate clients. It is the most direct private-side competitor to PathWest inside WA, competing head-to-head for collection-centre throughput, Medicare-billable work, and commercial testing.
• Pathology Queensland: Pathology Queensland is the public pathology service operated by Queensland Health, delivering diagnostic testing across Queensland's metropolitan and regional hospitals. Comparable to PathWest in scale-of-state remit, public-sector governance, and breadth of clinical services including forensic biology and specialised reference testing.
• Victorian Institute of Forensic Medicine: VIFM is the Victorian statutory body providing forensic medical and scientific services to the justice system, including forensic biology, toxicology, and pathology. Directly comparable to PathWest's Forensic Services line in mandate, accreditation regime, and reliance on a single state-government customer base.

Broad incumbents

• Healius: Healius (formerly Primary Health Care) is one of Australia's largest private healthcare operators, with a substantial pathology division operating QML, Laverty, Dorevitch, and other brands. Offers overlapping routine and specialised pathology services to the same medical-professional customer base that PathWest serves in WA, and competes for non-Medicare rebatable test volume.
• Australian Clinical Labs: Australian Clinical Labs is an ASX-listed private pathology operator providing a broad menu of routine and specialised pathology services across Australia. Competes with PathWest for private-bill and non-Medicare rebatable testing, particularly workplace, immigration, and insurance-related screening.
• Sonic Healthcare: Sonic Healthcare is the largest private pathology operator in Australia and a major international diagnostics player with operations across Australia, the US, Europe and the UK. Directly comparable to PathWest in core clinical-pathology capability, but broader in geographic and service scope, with significant private commercial testing that competes with PathWest's Commercial Services line.

Others

• Genomics England: Genomics England is a UK government-owned genomic medicine organisation operating large-scale whole-genome sequencing programmes for rare disease and cancer. Comparable to PathWest's Diagnostic Genomics and CGP work as a large, publicly funded, population-scale clinical genomics platform, despite operating in a different geography and healthcare system.

Emerging players

• Genomic Diagnostics (Healius Genomic Diagnostics): Genomic Diagnostics is an Australian provider of specialised genomic and molecular pathology testing, including reproductive, hereditary cancer, and rare disease panels. Overlaps with PathWest's Diagnostic Genomics portfolio and the $19M CGP programme's competitive set, particularly for non-hospital-based clinician referrals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/PathWestLMWA
• LinkedInlinkedin.com/company/pathwest-laboratory-medicine-wa

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pathwest Laboratory Medicine